Sébastien HAPDEY
Fonction : Physicien Médical
Groupe : Quantif
Publications associées
- Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers.
Cancers (Basel) · 2023 - Dosimetry for targeted radionuclide therapy in routine clinical practice : experts advice vs clinical evidence.
Eur J Nucl Med Mol Imaging · 2023 - Evaluation of the capability and reproducibility of RECIST 1.1. measurements by technologists in breast cancer follow-up: a pilot study.
Sci Rep. · 2023 - Synthetic MRI for Radiotherapy Planning for Brain and Prostate Cancers: Phantom Validation and Patient Evaluation.
Front Oncol · 2022 - Clinical and phantom validation of a deep learning based denoising algorithm for F-18-FDG PET images from lower detection counting in comparison with the standard acquisition.
EJNMMI Phys · 2022 - Respiratory gated multistatic PET reconstructions to delineate radiotherapy target volume in patients with mobile lung tumors.
Q J Nucl Med Mol Imaging · 2022 - First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer.
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer. · 2021 - Uptake of pineal gland visible on 18F-DOPA PET/CT with last generation of SiPM PET/CT.
Clin Nucl Med · 2020 - Correlations between baseline 18F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma.
EJNMMI Res · 2020 - Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images.
EJNMMI Phys · 2020 - Comparison of hypermetabolic and hypoxic volumes delineated on [18F] FDG an [18F] Fluoromisonidazole PET/CT in non-smal-cell lung cancer patients.
Mol Imaging Biol · 2020 - How to work together between nuclear medicine and radiotherapy departments ?
Cancer Radiother · 2020 - Tomographie par émission de positons (TEP) pour la radiothérapie : technique et innovations [PET technology: Latest advances and potential impact on radiotherapy].
Cancer Radiother · 2020 - Radiotherapy boost in patients with hypoxic lesions identified by F-FMISO PET/CT in non small cell lung carcinoma : can we expect a better survival outcome without toxicity ? (RTEP5 study).
EJNMMI · 2019 - Comparison of hypermetabolic and hypoxic volumes delineated on 18FDG an 18Fmisonidazole PET-CT in non-small cell lung cancer patients.
Mol Imaging Biol · 2019 - Définition of target volume : when et how can the radiation oncologist use PET ?
Cancer Radiother · 2019 - Définition of target volume: when et how can the radiation oncologist use PET?
Cancer Radiother;23(6-7) :745-752. · 2019